Skip to main content
Livermore
Livermore
ZHEN

US Bancorp

SEC CIK
0000036104
Latest filing
Aug 12, 2026

DNLI holding history

Denali Therapeutics Inc. in every 13F filed by US Bancorp, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

DNLI overviewAll 13F holders of DNLIFull Q2 2026 holdings

Shares (Q2 2026)
950
Value
$24.4K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of DNLI by US Bancorp, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026950$24.4K<0.1%+48+5.3%AddedHolders
Q1 2026902$17.3K<0.1%+68+8.2%AddedHolders
Q4 2025834$13.8K<0.1%+138+19.8%AddedHolders
Q3 2025696$10.1K<0.1%+255+57.8%AddedHolders
Q2 2025441$6.17K<0.1%−93−17.4%ReducedHolders
Q1 2025534$7.26K<0.1%−479−47.3%ReducedHolders
Q4 20241,013$20.6K<0.1%−155−13.3%ReducedHolders
Q3 20241,168$34.0K<0.1%−448−27.7%ReducedHolders
Q2 20241,616$37.5K<0.1%+863+114.6%AddedHolders
Q1 2024753$15.5K<0.1%+254+50.9%AddedHolders
Q4 2023499$10.7K<0.1%−341−40.6%ReducedHolders
Q3 2023840$17.3K<0.1%+255+43.6%AddedHolders
Q2 2023585$17.3K<0.1%−71−10.8%ReducedHolders
Q1 2023656$15.1K<0.1%+199+43.5%AddedHolders
Q4 2022457$12.7K<0.1%−46−9.1%ReducedHolders
Q3 2022503$15.0K<0.1%+46+10.1%AddedHolders
Q2 2022457$13.0K<0.1%−102−18.2%ReducedHolders
Q1 2022559$18.0K<0.1%+115+25.9%AddedHolders
Q4 2021444$20.0K<0.1%+6+1.4%AddedHolders
Q3 2021438$22.0K<0.1%−40−8.4%ReducedHolders
Q2 2021478$37.0K<0.1%+12+2.6%AddedHolders
Q1 2021466$27.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.